Skip to main content
NBP logo

NovaBridge Biosciences

NBPNASDAQHealthcareBiotechnology

$1.26Today:- (-)1Y −77.64%

As of Oct 16, 2026 close

Market cap
$149.28M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.26$6.79
Volume (live)
-
Avg. volume (3M)
532.06K

NovaBridge Biosciences (NBP) Cash Flow Statement

In fiscal 2025 (fiscal year ended Mar 31, 2026), NovaBridge Biosciences used CNY 20.60M of cash in operating activities and spent CNY 7.00K on capital expenditures. That left free cash flow of −CNY 20.60M.

NovaBridge Biosciences Cash Flow Statement Analysis

Values in billions CNY

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for NovaBridge Biosciences (NBP) - Annual data in billions CNY
BreakdownFY 2025FY 2025FY 2024FY 2024FY 2023FY 2022FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingMar 2026Dec 2025Mar 2025Dec 2024Dec 2023Mar 2023Dec 2022Dec 2021Dec 2020Mar 2020Dec 2018Dec 2017
Operating Activities
Net Income-0.09-0.18-0.36-0.10-0.21-2.51-0.28-2.330.47-1.45-0.40-0.30
Depreciation & Amortization0.000.000.010.000.000.060.000.030.020.020.010.00
Deferred Income Tax0.00-0.00-0.000.00-0.000.00-0.01-0.080.01
Stock Based Compensation0.010.01-0.010.000.010.360.010.610.490.370.000.01
Change in Working Capital0.020.02-0.020.00-0.040.550.020.39-0.240.180.150.03
Change in Accounts Receivable0.00-0.00-0.000.030.000.10-0.130.01-0.010.00
Change in Inventory0.00-0.00-0.000.030.00-0.030.000.000.000.00
Change in Accounts Payable0.00-0.00-0.000.00-0.110.000.000.000.00
Change in Other Working Capital0.020.00-0.020.01-0.040.49-0.120.22-0.110.170.160.03
Other Operating Activities0.040.040.010.010.160.430.060.32-0.310.020.040.00
Net Cash from Operating Activities-0.02-0.02-0.38-0.05-0.07-1.10-0.09-0.970.43-0.87-0.28-0.25
Investing Activities
Capital Expenditures0.000.000.000.000.00-0.050.00-0.03-0.01-0.01-0.01-0.02
Acquisitions0.00-0.00-0.000.00--0.01-0.26-0.220.000.09
Purchases of Investments-0.05-0.05-1.79-0.250.00-7.41-1.07-10.17-2.49-0.13-0.03-0.37
Sales/Maturities of Investments0.150.150.800.110.007.910.769.482.500.360.050.14
Other Investing Activities0.00-0.00-0.02-0.110.000.070.000.050.220.000.00
Net Cash from Investing Activities0.100.10-0.99-0.14-0.110.46-0.01-0.73-0.200.210.01-0.16
Financing Activities
Debt Repayment0.00-0.00-0.000.00-0.00-0.010.150.060.54
Common Stock Issued0.060.060.00-0.000.000.010.000.540.000.000.00
Common Stock Repurchased0.00-0.000.00-0.010.000.000.00-0.010.000.000.00
Dividends Paid0.00-0.00-0.000.00-0.000.00-0.010.000.00
Other Financing Activities0.000.000.000.000.000.040.000.592.910.001.420.22
Net Cash from Financing Activities0.060.060.000.00-0.010.040.000.593.440.151.480.76
Summary
Effect of Forex Changes on Cash0.000.00-0.330.000.040.390.06-0.13-0.110.020.060.00
Net Change in Cash0.140.14-1.71-0.24-0.15-0.21-0.08-1.243.57-0.491.270.35
Cash at Beginning of Period0.070.072.200.310.463.520.554.761.191.680.410.06
Cash at End of Period0.210.210.500.070.313.310.483.524.761.191.680.41
Free Cash Flow-0.02-0.02-0.38-0.05-0.07-1.15-0.09-1.000.43-0.88-0.30-0.27
Supplemental Disclosures
Interest Paid------0.00-0.00---
Income Taxes Paid-------0.00----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NovaBridge Biosciences Cash Flow

What is NovaBridge Biosciences's free cash flow?

NovaBridge Biosciences had negative free cash flow of CNY 20.60M in fiscal 2025 (fiscal year ended Mar 31, 2026), operating cash flow of −CNY 20.60M minus CNY 7.00K of capital expenditures.

How much does NovaBridge Biosciences spend on capital expenditures?

NovaBridge Biosciences spent CNY 7.00K on capital expenditures in fiscal 2025, compared with CNY 350.34K a year earlier.

Does NovaBridge Biosciences pay dividends or buy back shares?

NovaBridge Biosciences's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition